M&A
confidence high
sentiment positive
materiality 0.65
Certara completes $310M acquisition of Pinnacle 21, a clinical data compliance SaaS provider
Certara, Inc.
- Enterprise value $310M; ~$250M cash + 2,239,717 restricted shares to equityholders.
- Pinnacle 21 software validates CDISC compliance required by FDA and PMDA.
- Transaction expected to be accretive to Certara's revenue, growth, and adjusted EBITDA.
- Pinnacle 21 used by FDA, PMDA, and 22 of top 25 biopharma R&D spenders.